Imricor Medical Systems, Inc.
ASX:IMR.AX
1.685 (AUD) • At close June 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.552 | 0.408 | 0.417 | 0.199 | 0.278 | 0.538 | 0.33 | 0.366 | 0.425 | 0.278 | 0.585 | 0.055 | 0.316 | 0.686 | 0.283 | 0.283 | 0.352 | 0.352 |
| Cost of Revenue
| 0.936 | 0.948 | 0.79 | 0.942 | 0.948 | 1.395 | 1.444 | 1.148 | 0.733 | 0.367 | 0.377 | 0 | 0 | 0 | 0 | 0 | 0.107 | 0.107 |
| Gross Profit
| -0.384 | -0.54 | -0.373 | -0.742 | -0.67 | -0.857 | -1.114 | -0.782 | -0.308 | -0.09 | 0.208 | 0.055 | 0.316 | 0.686 | 0.283 | 0.283 | 0.244 | 0.244 |
| Gross Profit Ratio
| -0.696 | -1.325 | -0.896 | -3.731 | -2.408 | -1.593 | -3.376 | -2.135 | -0.725 | -0.323 | 0.355 | 1 | 1 | 1 | 1 | 1 | 0.695 | 0.695 |
| Reseach & Development Expenses
| 4.382 | 3.799 | 4 | 3.92 | 3.483 | 4.463 | 5.001 | 4.674 | 3.113 | 2.433 | 1.833 | 1.768 | 1.779 | 1.747 | 2.445 | 2.445 | 1.965 | 1.965 |
| General & Administrative Expenses
| 2.365 | 2.555 | 2.281 | 2.807 | 2.082 | 2.901 | 2.937 | 2.882 | 2.193 | 2.136 | 1.582 | 1.053 | 0.803 | 0.787 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 1.105 | 1.167 | 1.08 | 1.652 | 1.316 | 1.489 | 1.454 | 1.414 | 0.981 | 0.703 | 0.324 | 0.249 | 0.33 | 0.373 | 0 | 0 | 0 | 0 |
| SG&A
| 3.47 | 3.723 | 3.361 | 4.459 | 3.398 | 4.389 | 4.392 | 4.296 | 3.174 | 2.839 | 1.906 | 1.302 | 1.134 | 1.16 | 1.044 | 1.044 | 1.004 | 1.004 |
| Other Expenses
| 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 7.851 | 7.521 | 7.36 | 8.477 | 6.891 | 8.869 | 8.683 | 9.061 | 6.226 | 5.551 | 8.037 | 4.503 | 2.815 | 2.849 | 3.489 | 3.489 | 2.969 | 2.969 |
| Operating Income
| -8.235 | -8.061 | -7.734 | -9.121 | -7.551 | -9.709 | -10.507 | -9.752 | -6.595 | -5.362 | -3.531 | -3.016 | -2.597 | -2.221 | -3.272 | -3.272 | -2.725 | -2.725 |
| Operating Income Ratio
| -14.928 | -19.77 | -18.566 | -45.834 | -27.156 | -18.048 | -31.835 | -26.63 | -15.53 | -19.319 | -6.035 | -55.298 | -8.217 | -3.235 | -11.569 | -11.569 | -7.742 | -7.742 |
| Total Other Income Expenses Net
| -14.599 | 1.203 | -5.672 | -0.099 | -0.03 | -0.067 | 0.737 | -0.21 | -0.054 | -0.436 | -4.713 | -2.034 | -0.35 | -0.281 | -0.084 | -0.084 | -0.023 | -0.023 |
| Income Before Tax
| -22.835 | -6.858 | -13.406 | -9.22 | -7.581 | -9.776 | -9.77 | -9.962 | -6.649 | -5.798 | -8.244 | -5.05 | -2.946 | -2.502 | -3.355 | -3.355 | -2.747 | -2.747 |
| Income Before Tax Ratio
| -41.392 | -16.819 | -32.183 | -46.329 | -27.263 | -18.172 | -29.603 | -27.203 | -15.658 | -20.89 | -14.088 | -92.59 | -9.324 | -3.645 | -11.865 | -11.865 | -7.806 | -7.806 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 |
| Net Income
| -22.835 | -6.858 | -13.406 | -9.22 | -7.581 | -9.776 | -9.77 | -9.962 | -6.649 | -5.798 | -8.244 | -5.05 | -2.946 | -2.502 | -3.355 | -3.355 | -2.747 | -2.747 |
| Net Income Ratio
| -41.392 | -16.819 | -32.183 | -46.329 | -27.263 | -18.172 | -29.603 | -27.203 | -15.658 | -20.89 | -14.088 | -92.59 | -9.324 | -3.645 | -11.865 | -11.865 | -7.806 | -7.806 |
| EPS
| -0.089 | -0.036 | -0.083 | -0.061 | -0.051 | -0.068 | -0.072 | -0.079 | -0.057 | -0.056 | -0.107 | -0.115 | -0.07 | -0.06 | -0.035 | -0.035 | -0.029 | -0.029 |
| EPS Diluted
| -0.089 | -0.036 | -0.083 | -0.061 | -0.051 | -0.068 | -0.072 | -0.079 | -0.057 | -0.056 | -0.107 | -0.115 | -0.07 | -0.06 | -0.035 | -0.035 | -0.029 | -0.029 |
| EBITDA
| -7.857 | -7.692 | -7.381 | -8.767 | -7.178 | -9.369 | -10.15 | -9.42 | -6.295 | -5.134 | -3.338 | -2.952 | -2.555 | -2.184 | -3.207 | -3.207 | -2.652 | -2.652 |
| EBITDA Ratio
| -14.242 | -18.864 | -17.719 | -44.052 | -25.815 | -17.417 | -30.753 | -25.724 | -14.824 | -18.497 | -5.704 | -54.129 | -8.087 | -3.182 | -11.342 | -11.342 | -7.535 | -7.535 |